Valiant Laboratories (BOM:543998) Debt-to-Asset : 0.32 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Debt-to-Asset?

Valiant Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹107 Mil. Valiant Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹1,049 Mil. Valiant Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₹3,610 Mil. Valiant Laboratories's debt to asset for the quarter that ended in Sep. 2024 was 0.32.

Valiant Laboratories Debt-to-Asset Historical Data

The historical data trend for Valiant Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Debt-to-Asset Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

0.01

0.34

0.28

0.22

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial						0.28	-	0.22	-	0.32

Competitive Comparison of Valiant Laboratories's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Valiant Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valiant Laboratories's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valiant Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Valiant Laboratories's Debt-to-Asset falls into.

Valiant Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Valiant Laboratories's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(16.185	+	750.899)	/	3426.873
	=	0.22

Valiant Laboratories's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(106.578	+	1049.244)	/	3609.575
	=	0.32

Valiant Laboratories (BOM:543998) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Valiant Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Debt-to-Asset

Traded in Other Exchanges

VALIANTLAB:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines